Skip to main content
. 2021 Feb 26;12:640241. doi: 10.3389/fphar.2021.640241

TABLE 4.

Performance measures from 5-choice serial reaction time task: Standard conditions of 0.75 s SD, 5 s ITI, 100 trials. Psilocybin “low” and “high” performers (N = 8 per subgroup).

Subgroup Treatment #Correct trials #Incorrect trials #Missed trials %Correct %Hit PREM PSV Correct latency (s) Magazine latency (s) Total trials
Low performers Vehicle 53.5 ± 6.2 15.8 ± 1.9 18.8 ± 5.8 76.9 ± 2.1 60.6 ± 5.5 5.6 ± 1.5 29.3 ± 2.7 0.83 ± 0.07 3.16 ± 0.44 88.0 ± 5.1
Psilocybin (0.05 mg/kg) 62.4 ± 7.6* 13.0 ± 2.5 14.4 ± 5.4 81.8 ± 3.2* 69.1 ± 5.3* 6.5 ± 1.6 30.3 ± 6.5 0.72 ± 0.04* 4.77 ± 1.88 89.8 ± 7.7
Psilocybin (0.1 mg/kg) 61.9 ± 5.1* 13.5 ± 2.1 14.3 ± 4.9 82.5 ± 1.9* 70.3 ± 4.6* 8.3 ± 2.7 35.1 ± 7.9 0.76 ± 0.05* 6.51 ± 2.66 89.6 ± 6.9
High performers Vehicle 82.4 ± 3.0 6.4 ± 0.4 11.3 ± 3.0 92.8 ± 0.5 82.4 ± 3.0 5.0 ± 1.7 12.5 ± 2.0 0.63 ± 0.03 2.18 ± 0.18 100.0 ± 0.0
Psilocybin (0.05 mg/kg) 81.9 ± 2.4 7.4 ± 1.8 10.8 ± 1.8 91.8 ± 1.9 81.9 ± 2.4 5.0 ± 1.8 14.3 ± 2.5 0.64 ± 0.03 2.37 ± 0.18 100.0 ± 0.0
Psilocybin (0.1 mg/kg) 78.6 ± 4.7 6.8 ± 1.9 12.6 ± 2.7 91.9 ± 2.2 79.9 ± 3.9 3.3 ± 1.4 16.3 ± 4.7 0.66 ± 0.04 2.53 ± 0.22 98.0 ± 1.6